BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26649862)

  • 1. Comparative analysis of basaloid and conventional squamous cell carcinomas of the esophagus: prognostic relevance of clinicopathological features and protein expression.
    Sato-Kuwabara Y; Fregnani JH; Jampietro J; Carvalho KC; Franco CP; da Costa WL; Coimbra FJ; Soares FA
    Tumour Biol; 2016 May; 37(5):6691-9. PubMed ID: 26649862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical and oncogenetic analyses of the esophageal basaloid squamous cell carcinoma in comparison with conventional squamous cell carcinomas.
    Imamhasan A; Mitomi H; Saito T; Hayashi T; Takahashi M; Kajiyama Y; Yao T
    Hum Pathol; 2012 Nov; 43(11):2012-23. PubMed ID: 22607702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis of clinicopathological factors and survival between esophageal basaloid squamous cell carcinoma and conventional esophageal squamous cell carcinoma.
    Jiang D; Wang H; Deng M; Song Q; Liu Y; Peng R; Xu L; Su J; Xu C; Hou Y
    Eur J Surg Oncol; 2023 May; 49(5):958-963. PubMed ID: 36588005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 15 is an Effective Indicator for Progression and Malignancy of Esophageal Squamous Cell Carcinomas.
    Shen YH; Xu CP; Shi ZM; Zhang YJ; Qiao YG; Zhao HP
    Asian Pac J Cancer Prev; 2016; 17(9):4217-4222. PubMed ID: 27797221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of adhesion proteins (E-cadherin and β-catenin) and cell proliferation (Ki-67) at the invasive tumor front in conventional oral squamous cell and basaloid squamous cell carcinomas.
    Pereira CH; Morais MO; Martins AF; Soares MQ; Alencar Rde C; Batista AC; Leles CR; Mendonça EF
    Arch Oral Biol; 2016 Jan; 61():8-15. PubMed ID: 26476747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of CFL1 and N-WASP in esophageal squamous cell carcinoma and its correlation with clinicopathological features.
    Wang WS; Zhong HJ; Xiao DW; Huang X; Liao LD; Xie ZF; Xu XE; Shen ZY; Xu LY; Li EM
    Dis Esophagus; 2010 Aug; 23(6):512-21. PubMed ID: 20095995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oesophageal basaloid squamous cell carcinoma: a unique clinicopathological entity with telomerase activity as a prognostic indicator.
    Lam KY; Law S; Luk JM; Wong J
    J Pathol; 2001 Nov; 195(4):435-42. PubMed ID: 11745675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and prognostic significance of Mucin 13 and Mucin 20 in esophageal squamous cell carcinoma.
    Wang H; Shen L; Lin Y; Shi Q; Yang Y; Chen K
    J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C74-9. PubMed ID: 26323930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Kim SH; Kim JH; Yu EJ; Lee KW; Park CK
    Histol Histopathol; 2012 Jan; 27(1):49-58. PubMed ID: 22127596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PML protein as a prognostic molecular marker for patients with esophageal squamous cell carcinomas receiving primary surgery.
    Yen CC; Tsao YP; Chen PC; Wu YC; Liu JH; Pan CC; Liu CY; Tzeng CH; Chen PM; Chen YJ; Lin CH; Hsu WH
    J Surg Oncol; 2011 Jun; 103(8):761-7. PubMed ID: 21240990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basaloid squamous cell carcinoma of the esophagus: assessment for high-risk human papillomavirus and related molecular markers.
    Bellizzi AM; Woodford RL; Moskaluk CA; Jones DR; Kozower BD; Stelow EB
    Am J Surg Pathol; 2009 Nov; 33(11):1608-14. PubMed ID: 19738459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basaloid squamous cell carcinoma of the esophagus: diagnosis and prognosis.
    Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE
    Cancer; 1997 May; 79(10):1871-8. PubMed ID: 9149011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
    Hoshino M; Fukui H; Ono Y; Sekikawa A; Ichikawa K; Tomita S; Imai Y; Imura J; Hiraishi H; Fujimori T
    Pathobiology; 2007; 74(1):15-21. PubMed ID: 17496429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of Oct4 in different histological subtypes of esophageal squamous cell carcinomas in different clinical conditions.
    Vaiphei K; Sinha SK; Kochhar R
    Asian Pac J Cancer Prev; 2014; 15(8):3519-24. PubMed ID: 24870750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of malignancy and the prognosis of esophageal cancer based on an immunohistochemical study (p53, E-cadherin, epidermal growth factor receptor).
    Inada S; Koto T; Futami K; Arima S; Iwashita A
    Surg Today; 1999; 29(6):493-503. PubMed ID: 10385363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gli1, a potential regulator of esophageal cancer stem cell, is identified as an independent adverse prognostic factor in esophageal squamous cell carcinoma.
    Yang Z; Cui Y; Ni W; Kim S; Xuan Y
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):243-254. PubMed ID: 27680978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Sato T; Sugiyama A; Miyagawa S
    Am J Gastroenterol; 2004 Sep; 99(9):1667-74. PubMed ID: 15330899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.